These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12901378)

  • 21. Hepatitis A virus (HAV) packaging size limit.
    Konduru K; Nakamura SM; Kaplan GG
    Virol J; 2009 Nov; 6():204. PubMed ID: 19922643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of anti-idiotypic antibodies mimicking antibody- and receptor-binding sites on hepatitis A virus.
    Kiyohara T; Totsuka A; Yoneyama T; Ishii K; Ito T; Wakita T
    Arch Virol; 2009; 154(8):1263-9. PubMed ID: 19578927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electron microscopy of an alpha-dystroglycan fragment containing receptor sites for lymphocytic choriomeningitis virus and laminin, and use of the receptoid body as a reagent to neutralize virus.
    Kunz S; Calder L; Oldstone MB
    Virology; 2004 Aug; 325(2):207-15. PubMed ID: 15246261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations conferring resistance to neutralization by a soluble form of the neurotrophin receptor (p75NTR) map outside of the known antigenic sites of the rabies virus glycoprotein.
    Langevin C; Tuffereau C
    J Virol; 2002 Nov; 76(21):10756-65. PubMed ID: 12368318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HAVcR-1 reduces the integrity of human endothelial tight junctions.
    Martin TA; Harrison GM; Mason MD; Jiang WG
    Anticancer Res; 2011 Feb; 31(2):467-73. PubMed ID: 21378325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural basis for neutralization of hepatitis A virus informs a rational design of highly potent inhibitors.
    Cao L; Liu P; Yang P; Gao Q; Li H; Sun Y; Zhu L; Lin J; Su D; Rao Z; Wang X
    PLoS Biol; 2019 Apr; 17(4):e3000229. PubMed ID: 31039149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perinuclear accumulation of hepatitis A virus proteins, RNA, and particles and ultrastructural alterations in infected cells.
    Klinger MH; Kämmerer R; Hornei B; Gauss-Müller V
    Arch Virol; 2001 Dec; 146(12):2291-307. PubMed ID: 11811680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental hepatitis A virus (HAV) infection in Callithrix jacchus: early detection of HAV antigen and viral fate.
    Pinto MA; Marchevsky RS; Baptista ML; de Lima MA; Pelajo-Machado M; Vitral CL; Kubelka CF; Pissurno JW; Franca MS; Schatzmayr HG; Gaspar AM
    Exp Toxicol Pathol; 2002 Feb; 53(6):413-20. PubMed ID: 11930901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stable growth of wild-type hepatitis A virus in cell culture.
    Konduru K; Kaplan GG
    J Virol; 2006 Feb; 80(3):1352-60. PubMed ID: 16415012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pathogenic picornavirus acquires an envelope by hijacking cellular membranes.
    Feng Z; Hensley L; McKnight KL; Hu F; Madden V; Ping L; Jeong SH; Walker C; Lanford RE; Lemon SM
    Nature; 2013 Apr; 496(7445):367-71. PubMed ID: 23542590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis a virus: molecular detection and typing.
    Sánchez G; Villena C; Bosch A; Pintó RM
    Methods Mol Biol; 2004; 268():103-14. PubMed ID: 15156022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular characterization of hepatitis A virus from a large outbreak from Kerala, India.
    Arankalle VA; Sarada Devi KL; Lole KS; Shenoy KT; Verma V; Haneephabi M
    Indian J Med Res; 2006 Jun; 123(6):760-9. PubMed ID: 16885597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and serologic tracing of a transfusion-transmitted hepatitis A virus.
    Gowland P; Fontana S; Niederhauser C; Taleghani BM
    Transfusion; 2004 Nov; 44(11):1555-61. PubMed ID: 15504159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth of hepatitis A virus in a mouse liver cell line.
    Feigelstock DA; Thompson P; Kaplan GG
    J Virol; 2005 Mar; 79(5):2950-5. PubMed ID: 15709014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Viruses in the feces of patients with viral hepatitis and other enterovirus infections].
    Andzhaparidze AG; Balaian MS; Savinskaia SS; Mamedov MK; Annenkov AE
    Vopr Virusol; 1984; 29(5):559-66. PubMed ID: 6097043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incomplete neutralization of hepatitis A virus in vitro due to lipid-associated virions.
    Lemon SM; Binn LN
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2501-5. PubMed ID: 2997380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection and characterization of hepatitis A virus in water samples in Thailand.
    Kittigul L; Uthaisin A; Ekchaloemkiet S; Utrarachkij F; Luksamijarulkul P
    J Appl Microbiol; 2006 Jun; 100(6):1318-23. PubMed ID: 16696679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of infectious hepatitis A virus by integrated cell culture/strand-specific reverse transcriptase-polymerase chain reaction.
    Jiang YJ; Liao GY; Zhao W; Sun MB; Qian Y; Bian CX; Jiang SD
    J Appl Microbiol; 2004; 97(5):1105-12. PubMed ID: 15479428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis A virus replication: an intermediate in the uncoating process.
    Bishop NE
    Intervirology; 2000; 43(1):36-47. PubMed ID: 10773736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of enteroviruses and hepatitis A virus in water by consensus primer multiplex RT-PCR.
    Li JW; Wang XW; Yuan CQ; Zheng JL; Jin M; Song N; Shi XQ; Chao FH
    World J Gastroenterol; 2002 Aug; 8(4):699-702. PubMed ID: 12174381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.